Newmarket Cardiology Research Group

Newmarket, Ontario l3y -8c3

0 studies enrolling now · 6 studies all time

What they study most

Atherosclerosis, Cardiovascular Disease, Cardiovascular Diseases, Cerebrovascular Accident, Coronary Disease, Heart Diseases, High Cardiovascular Risk, Hyperlipidemia, Myocardial Infarction, Obesity, Overweight, Type 2 Diabetes

Studies at this site

• Cardiovascular Inflammation Reduction Trial — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Niacin Plus Statin to Prevent Vascular Events — Stopped early